ARWR - Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.